Impact of pre-transplantation minimal residual disease (MRD) on the outcome of Allogeneic hematopoietic stem cell transplantation for acute leukemia-Reference-Cited by-同舟云学术

Impact of pre-transplantation minimal residual disease (MRD) on the outcome of Allogeneic hematopoietic stem cell transplantation for acute leukemia

Published:2021-01-01 Issue:1 Volume:26 Page:295-300
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Shen Xing¹²,Pan Jing¹²,Qi Chenchen¹²,Feng Yuan¹²,Wu Hanxin¹²,Qian Sixuan¹²,Lu Hua¹²,Chen Lijuan¹²,Li Jianyong¹²,Miao Kourong¹²,Qiu Hairong¹²,Zhu Han¹²^ORCID

Affiliation:

1. Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People’s Republic of China

2. Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, People’s Republic of China

Funder

National Natural Science Foundation of China

Jiangsu Provincial Special Program of Medical Science

the Priority Academic Program Development of Jiangsu Higher Education Institute

National Public Health Grand Research Foundation

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.1889162